Home > Balance Sheet > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Total Non-Current Liabilities

    Back to Balance Sheet
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2017Mar2016
Total Non-Current Liabilities ₹10.00 Cr₹8.66 Cr₹7.76 Cr₹7.73 Cr₹6.27 Cr

What is the latest Total Non-Current Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Total Non-Current Liabilities ratio of SYNCOM FORMULATIONS (INDIA) is ₹10.00 Cr based on Mar2024 Consolidated results.
Year Total Non-Current Liabilities
Mar2024₹10.00 Cr
Mar2023₹8.66 Cr
Mar2022₹7.76 Cr
Mar2017₹7.73 Cr
Mar2016₹6.27 Cr

How is Total Non-Current Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?

Years Total Non-Current Liabilities % Change
Mar2024 ₹10.00 Cr
15.49
Mar2023 ₹8.66 Cr
11.53
Mar2022 ₹7.76 Cr
0.36
Mar2017 ₹7.73 Cr
23.39
Mar2016 ₹6.27 Cr -

Compare Total Non-Current Liabilities of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,442.9 Cr -9.7% -13% 7.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹382,430.0 Cr -3% -8.7% 4.1% Stock Analytics
DIVIS LABORATORIES ₹145,410.0 Cr -4.7% -4.5% 58.5% Stock Analytics
CIPLA ₹113,950.0 Cr -4.3% -3.2% -3.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹99,682.3 Cr -3% -12.3% 13.8% Stock Analytics
DR REDDYS LABORATORIES ₹93,261.6 Cr -3% -6.5% -12.7% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-9.7%

-13%

7.7%

SENSEX

-3.4%

-4.4%

0.6%


You may also like the below Video Courses